Market capitalization, the total value of publicly traded biotech companies (U.S.) at market prices, was $360 billion as of late April 2008 (based on stocks tracked by BioWorld).
- For Students
- For Teachers
- Programs
- International BioGENEius Challenge
- Testimonials
- Volunteer Opportunities
- U.S. National BioGENEius Challenge
- Local BioGENEius Challenges
- At-Large BioGENEius Challenge Competition
- Your World Magazine
- About the Institute
- Supporters
- What is Biotechnology?
